stockportfolio.pro
Tactile Systems Technology, Inc. (TCMD)
Healthcare · Medical Devices · NasdaqGM
Tactile Systems Technology, Inc. revenue & earnings — last 10 fiscal years
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $84.54M | $109.28M | $143.75M | $189.49M | $187.13M | $208.06M | $246.78M | $274.42M | $292.98M | $329.52M |
| Gross profit | $61.60M | $80.27M | $102.26M | $134.24M | $132.81M | $148.21M | $175.98M | $195.13M | $216.69M | $250.15M |
| Net income | $2.88M | $5.86M | $6.62M | $10.97M | $-620,000 | $-11.81M | $-17.87M | $28.52M | $16.96M | $19.09M |
| Net margin | 3.4% | 5.4% | 4.6% | 5.8% | -0.3% | -5.7% | -7.2% | 10.4% | 5.8% | 5.8% |
Source: Tactile Systems Technology, Inc. SEC filings (10-K). 12 years of history available in the interactive view.
What growth is priced into TCMD stock?
At today's market cap of $582.97M, Tactile Systems Technology, Inc. is priced for free-cash-flow growth of about 3.3% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $40.28M from the FY ending 2025-12-31). For comparison, free cash flow actually grew 122.7%/yr over the last five fiscal years and revenue 12%/yr, computed from its SEC filings. This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 12 years of Tactile Systems Technology, Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track TCMD in your portfolio →
Tactile Systems Technology, Inc. financial history by metric
About Tactile Systems Technology, Inc.
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
Tactile Systems Technology, Inc. — frequently asked questions
What is Tactile Systems Technology, Inc.'s revenue?
Tactile Systems Technology, Inc. (TCMD) reported revenue of $329.52M for fiscal year 2025, up 12.5% from the prior year, according to its SEC filings.
Is Tactile Systems Technology, Inc. profitable?
Yes. TCMD earned net income of $19.09M in fiscal 2025, a net margin of 5.8%.
What is TCMD's P/E ratio?
Tactile Systems Technology, Inc. trades at a price-to-earnings ratio of about 29.7 based on the latest data in our nightly-refreshed cache.
How fast is Tactile Systems Technology, Inc. growing?
TCMD's revenue grew at roughly 12.0% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does Tactile Systems Technology, Inc. have?
As of fiscal year 2025, TCMD carried roughly $0 in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Tactile Systems Technology, Inc.'s gross margin?
TCMD's gross margin was 75.9% in fiscal 2025 — gross profit of $250.15M on revenue of $329.52M.
What is Tactile Systems Technology, Inc.'s market cap?
Tactile Systems Technology, Inc. (TCMD) has a market capitalization of about $582.97M, based on the latest data in our nightly-refreshed cache.
When does Tactile Systems Technology, Inc.'s fiscal year end?
TCMD's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
What growth is priced into TCMD stock?
At today's market cap of $582.97M, Tactile Systems Technology, Inc. is priced for free-cash-flow growth of about 3.3% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $40.28M from the FY ending 2025-12-31). For comparison, free cash flow actually grew 122.7%/yr over the last five fiscal years and revenue 12%/yr, computed from its SEC filings.
Where does this data come from?
All figures are computed from Tactile Systems Technology, Inc.'s official SEC filings (10-K and 10-Q), covering 12 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.